order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting immunostaining in relation to complex human pathologies.
TCR Screening ServicesTest your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding. Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Antibodies to every target in the human genome | LSBio
LSBio offers antibodies for multiple applications, many species, and in both conjugated and unconjugated forms. Each Antibody indicates the applications for which it has been tested, such as Western, ELISA, Flow, Immunohistochemistry on frozen (IHC-F) or formalin-fixed paraffin tissues (IHC-P). Subsets of these antibodies have also been extensively tested for their IHC applications.
The IHCplus™ Antibodies have been tested in IHC against a broad panel of normal human formalin-fixed paraffin-embedded (FFPE) tissue types and demonstrate excellent sensitivity and specificity for detecting the target protein.
The PathPlus™ Antibodies have undergone additional validation to evaluate their performance within a particular research area or application, such as cancer or neuroscience. The latest release of the LSBio PathPlus™ Cancer Antibodies, are a collection of best-in-class IHC reagents for the detection of 200 molecular pathology cancer targets. Future releases will expand on the number of antibodies to cancer targets, as well as introduce top performing antibodies within other key research areas.
